M
Mohamed Mustapha Noordin
Researcher at Universiti Putra Malaysia
Publications - 70
Citations - 920
Mohamed Mustapha Noordin is an academic researcher from Universiti Putra Malaysia. The author has contributed to research in topics: Abdominal wall & Viral replication. The author has an hindex of 15, co-authored 69 publications receiving 782 citations.
Papers
More filters
Journal ArticleDOI
Antiviral Activity of Resveratrol against Human and Animal Viruses
TL;DR: This review highlights the antiviral mechanisms of resveratrol in human and animal viral infections and how some of these effects are associated with the antioxidant properties of the compound.
Journal Article
Effects of copper overload on hepatic lipid peroxidation and antioxidant defense in rats.
TL;DR: Excessive Cu accumulation in the liver depressed SOD and GSH-Px activities and resulted in high MDA in serum and liver homogenate due to the lipid peroxidation induced by the Cu overload.
Journal ArticleDOI
Effects of Momordica charantia on pancreatic histopathological changes associated with streptozotocin-induced diabetes in neonatal rats.
TL;DR: The results suggest that oral feeding of MC fruit extract may have a significant role in the renewal of pancreatic β-cells in the nSTZ rats.
Journal ArticleDOI
Antihypertensive and cardiovascular effects of catechin-rich oil palm (Elaeis guineensis) leaf extract in nitric oxide-deficient rats.
Juliana Md. Jaffri,Suhaila Mohamed,Nordanial Rohimi,Intan Natasya Ahmad,Mohamed Mustapha Noordin,Yazid Abdul Manap +5 more
TL;DR: Although OPLE showed good antihypertensive and antioxidant effects under NO deficiency, it was not hypotensive to normal rats and produced no chronic cardiovascular toxicity in any of the rats throughout the 12-week study.
Journal ArticleDOI
Morinda citrifolia edible leaf extract enhanced immune response against lung cancer.
Swee-Ling Lim,Yong Meng Goh,Mohamed Mustapha Noordin,Heshu Sulaiman Rahman,Hemn Hassan Othman,Nurul Ain Abu Bakar,Suhaila Mohamed +6 more
TL;DR: The 300 mg kg (-1)Morinda citrifolia leaf 50% ethanolic extract showed promising potential as a complementary therapeutic dietary supplement which was more effective than the 50 mg kg(-1) erlotinib in suppressing lung adenocarcinoma.